Atlas FDA

BOSTON EQUALENS(ITAFLUOROFOCON A)/EQUALENS II(OPRIFOCON A)

FDA premarket approval P860022/S052 · decided 2000-02-04

Approval details

PMA number
P860022
Supplement
S052
Supplement type
THIRTY DAY TRACK
Supplement reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
BOSTON EQUALENS(ITAFLUOROFOCON A)/EQUALENS II(OPRIFOCON A)
Generic name
Lens, contact (other material) - daily
Applicant
Bausch & Lomb
Date received
2000-01-05
Decision date
2000-02-04
Days to decision
30 days
Decision code
APPR
Product code
HQD
Advisory committee
Ophthalmic
Expedited review
No
Location
Rochester, NY
Statement
Approval under a 30-day notice for addition of one finishing laboratory, Procornea Nederland BV, Kollergan9, NL-6961 LZ Eerbeek, The Netherlands, to become an additional manufacturing and distributino site for the referenced devices.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Stellaris Elite vision enhancement system (K170052)Bausch+Lomb2017-04-19
Stellaris Elite Vision Enhancement System (K162342)Bausch+Lomb2017-03-24
STELLARIS PC VISION ENHANCEMENT SYSTEM (K133486)Bausch & Lomb2014-03-12
STELLARIS VISION ENHANCEMENT SYSTEM (K133242)Bausch & Lomb2014-02-14
BAUSCH & LOMB INJECTOR SYSTEM (K131958)Bausch & Lomb2014-01-09
BAUSCH + LUMB, VIS100 INJECTOR SYSTEM (K133146)Bausch & Lomb2014-01-03
EASY-LOAD LENS DELIVERY SYSTEM (K132481)Bausch & Lomb2013-12-27
CRYSTALSERT DELIVERY SYSTEM (K132593)Bausch & Lomb2013-09-17